HeraMED Limited (ASX: HMD)
Health Care · Health Care Equipment & Supplies · AU
AU$0.04
-7.14% today · 0.0% 1Y
HeraMED Limited (ASX: HMD) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $31.53M and employs 6 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.03 and 0.06.
Tweenvest scores HeraMED Limited across four factors: quality 36/100, value 73/100, growth 100/100. Its strongest factor is growth.
HMD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.53M
- Revenue (TTM)
- $228.60K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.01
- 52-week high
- AU$0.06
- 52-week low
- AU$0.03
- Avg volume (3M)
- —
- Shares outstanding
- 1.16B
- Employees
- 6
- Next earnings
- —
About HeraMED Limited
HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
- ISIN
- AU0000028367
- Founded
- 2011
- Listed since
- Dec 11, 2018
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Q-linea AB (publ)OM: QLINEA | $31.93M | Skr16.85 | -1.17% |
| Perfect Medical Industry Co., Ltd.TPEX: 6543 | $31.85M | NT$17.75 | -0.84% |
| Rockwell Medical, Inc.NasdaqCM: RMTI | $31.80M | $7.89 | -8.79% |
| Genoray Co., Ltd.KOSDAQ: A122310 | $31.58M | ₩3,335.00 | +0.15% |
| Yash Optics & Lens LimitedNSEI: YASHOPTICS | $31.50M | Rs123.10 | -9.08% |
| Milestone Scientific Inc.NYSEAM: MLSS | $31.06M | $0.35 | -7.41% |
| JMI Syringes & Medical Devices LimitedDSE: JMISMDL | $30.75M | Tk126.00 | -1.64% |
| Bio-Works Technologies AB (publ)NGM: BIOWKS | $30.66M | Skr3.06 | -2.86% |
Figures last refreshed Oct 11, 2026.